Home > Insider Trading > Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc. (IOVA)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
21 - 30
Next >>

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript

Operator: Welcome to the Iovance Biotherapeutics Conference Call to discuss the First Quarter 2024 Results and recent Corporate Updates. My name is Livia, and I'll be your operator for today's call.

Keep Reading →

May 10th, 2024 - News Transcripts

5 Best Healthcare Stocks to Buy Under $20

In this article, we will be taking a look at the 5 best healthcare stocks to buy under $20.

Keep Reading →

April 20th, 2024 - Hedge Funds News

Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks

In this article, we will take a detailed look at Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks. For a quick overview of such stocks, read our article Billionaire Paul Tudor Jones and...

Keep Reading →

March 15th, 2024 - Hedge Funds Insider Trading News

5 Best Biotech Stocks To Buy Under $20

In this article, we are going to take a closer look at five best biotech stocks to buy under $20.

Keep Reading →

March 13th, 2024 - Hedge Funds News

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q4 2023 Earnings Call Transcript

Iovance Biotherapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.45 EPS, expectations were $-0.44. Iovance Biotherapeutics, Inc.

Keep Reading →

February 29th, 2024 - News Transcripts

5 Stocks With Heavy Insider Buying In 2024

Wayne Rothbaum is a board member at California-based Iovance Biotherapeutics, Inc (NASDAQ:IOVA).

Keep Reading →

February 29th, 2024 - Insider Trading News

5 Best Short Squeeze Stocks To Buy Now

In this piece, we will take a look at the five best short squeeze stocks to buy now.

Keep Reading →

February 22nd, 2024 - Hedge Funds

5 Most Promising Cancer Stocks According to Analysts

In this piece, we will take a look at the five most promising cancer stocks according to analysts.

Keep Reading →

December 18th, 2023 - News

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q3 2023 Earnings Call Transcript

Operator: Welcome to the Iovance Biotherapeutics Third Quarter and Year-to-Date 2023 Financial Results and Corporate Update Conference Call.

Keep Reading →

November 8th, 2023 - News Transcripts

Should You Exit Iovance Biotherapeutics (IOVA) Following the Recent Uncertainty?

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here.

Keep Reading →

October 24th, 2023 - Hedge Fund Investor Letters News